G. Denissov

发表

Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017

Richard A. White, R. Pebody, K. Innos, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020

Richard A. White, P. Klepac, H. Uphoff, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Excess mortality among the elderly in European countries, December 2014 to February 2015.

R. Pebody, A. Páldy, A. Baburin, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Impact of the COVID-19 pandemic on total, sex- and age-specific all-cause mortality in 20 countries worldwide during 2020: results from the C-MOR project

C. Demetriou, P. Klepac, Inbar Zucker, 2022, International journal of epidemiology.

Sharp decrease in observed cerebrovascular mortality may be due to certification and coding

G. Denissov, 2016, Scandinavian journal of public health.

Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe.

P. Griffiths, J. Mounteney, I. Giraudon, 2015, The International journal on drug policy.

Fatal poisoning in Estonia 2000-2009. Trends in illegal drug-related deaths.

M. Väli, J. Tuusov, M. Tõnisson, 2013, Journal of forensic and legal medicine.

The impact of changing classifications on official fatal poisoning figures

M. Väli, D. Lepik, J. Tuusov, 2012 .

REPORT TO THE EMCDDA by the Reitox National Focal Point ESTONIA DRUG SITUATION 2003

A. Talu, Katri Abel, A. Neuman, 2003 .

Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020

Céline Caserio-Schönemann, Helmut Uphoff, Ahmed Farah, 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Evidence of overestimating prostate cancer mortality in Estonia: a population-based study

K. Innos, K. Lang, K. Paapsi, 2022, Scandinavian journal of urology.

European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?

J. Mossong, H. Uphoff, R. Pebody, 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Excess all-cause mortality and COVID-19-related mortality: a temporal analysis in 22 countries, from January until August 2020

C. Demetriou, P. Klepac, Inbar Zucker, 2021, International journal of epidemiology.

Institute of Experimental and Clinical Medicine Estonian Drug Monitoring Centre Estonian National Focal Point ESTONIA DRUG SITUATION 2002

A. Talu, Katri Abel, G. Denissov, 2003 .

Progressing towards tuberculosis elimination in the European Union and European Economic Area.

O. Nyrén, A. Plymoth, A. Páldy, 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Preventable premature deaths (PYLL) in Northern Dimension partnership countries 2003-13.

P. Jousilahti, Marita Friberg, K. Mackiewicz, 2019, European journal of public health.

Fentanyls: Are we missing the signs? Highly potent and on the rise in Europe.

P. Griffiths, I. Giraudon, G. Denissov, 2015, The International journal on drug policy.

Magnitude and determinants of excess total, age-specific and sex-specific all-cause mortality in 24 countries worldwide during 2020 and 2021: results on the impact of the COVID-19 pandemic from the C-MOR project

K. Davletov, T. Hagen, K. Athanasakis, 2024, BMJ Global Health.